SCHEMBL29458693

SCHEMBL29458693

CCNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C5CCOC5)cc4)cnc3N)on2)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 19/20 0.59
▸ ATM Q13315 11/20 0.59
▸ PRKDC P78527 6/20 0.59
▸ GSK3B P49841 3/20 0.49
▸ JAK2 O60674 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ KIT P10721 1/20 0.49
▸ SERPINA2 P20848 1/20 0.49
▸ PIK3R1 P27986 1/20 0.49
▸ FLT4 P35916 1/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ PIK3CA P42336 1/20 0.49
▸ MTOR P42345 1/20 0.49
▸ SYK P43405 1/20 0.49
▸ GSK3A P49840 1/20 0.49
▸ MAP3K9 P80192 1/20 0.49
▸ KCNH2 Q12809 1/20 0.49
▸ MERTK Q12866 1/20 0.49
▸ DYRK2 Q92630 1/20 0.49
▸ FEN1 P39748 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3061766 1.00 ATR (0.59) ATRATMPRKDCGSK3BJAK2
SCHEMBL20433701 1.00 ATR (0.59) ATRATMPRKDCGSK3BJAK2
SCHEMBL2482588 0.93 ATR (0.62) ATRATMPRKDCGSK3BJAK2
SCHEMBL3046834 0.92 ATR (0.56) ATRATMPRKDCGSK3BJAK2
SCHEMBL3052964 0.92 ATR (0.52) ATRATMPRKDCGSK3BJAK2
SCHEMBL3042320 0.90 ATR (0.61) ATRATMPRKDCGSK3BJAK2
SCHEMBL3042317 0.90 ATR (0.61) ATRATMPRKDCGSK3BJAK2
SCHEMBL3062864 0.89 ATR (0.56) ATRATMPRKDCGSK3BJAK2
SCHEMBL29458595 0.89 ATR (0.56) ATRATMPRKDCGSK3BJAK2
SCHEMBL20433615 0.89 ATR (0.55) ATRATMPRKDCGSK3BJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354650-B1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMA (US) 2022-02-16 — — EP disclosed
Send feedback